| Fused and substituted pyrimidine derivatives as profound anti-cancer agents N Abbas, GSP Matada, PS Dhiwar, S Patel, G Devasahayam Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2021 | 27 | 2021 |
| Development of fused and substituted pyrimidine derivatives as potent anticancer agents (a review) N Abbas, PMG Swamy, P Dhiwar, S Patel, D Giles Pharmaceutical Chemistry Journal 54, 1215-1226, 2021 | 26* | 2021 |
| Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer GS Purawarga Matada, PS Dhiwar, N Abbas, E Singh, A Ghara, A Das, ... Journal of Biomolecular Structure and Dynamics 40 (13), 6183-6192, 2022 | 22 | 2022 |
| Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a r eview E Singh, GSP Matada, N Abbas, PS Dhiwar, A Ghara, A Das Inflammopharmacology 29 (5), 1347-1355, 2021 | 22 | 2021 |
| DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agent GSP Matada, A Das, PS Dhiwar, A Ghara Medicinal Chemistry Research 30 (3), 535-551, 2021 | 22 | 2021 |
| Pharmacophore modeling, virtual screening, molecular docking and dynamics studies for the discovery of HER2-tyrosine kinase inhibitors: An in-silico approach GSP Matada, PS Dhiwar, N Abbas, E Singh, A Ghara, R Patil, ... Journal of Molecular Structure 1257, 132531, 2022 | 10 | 2022 |
| Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor … R Pal, G Teli, GSP Matada, PS Dhiwar Journal of Molecular Structure, 136021, 2023 | 9 | 2023 |
| Discoidin domain receptor inhibitors as anticancer agents: A systematic review on recent development of DDRs inhibitors, their resistance and structure activity relationship GP Shenoy, R Pal, GSP Matada, E Singh, NM Raghavendra, PS Dhiwar Bioorganic Chemistry 130, 106215, 2023 | 9 | 2023 |
| Design, Synthesis, In silico and in vitro evaluation of novel pyrimidine derivatives as EGFR inhibitors GSP Matada, N Abbas, PS Dhiwar, R Basu, G Devasahayam Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2021 | 8 | 2021 |
| An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review SSGA Prasad Sanjay Dhiwar, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal ... Journal of Biomolecular Structure and Dynamics, 1-18, 2023 | 7* | 2023 |
| Discovery of potential Aurora-A kinase inhibitors by 3D QSAR pharmacophore modeling, virtual screening, docking, and MD simulation studies G Swamy PM, N Abbas, PS Dhiwar, E Singh, A Ghara, A Das Journal of Biomolecular Structure and Dynamics 41 (1), 125-146, 2023 | 7 | 2023 |
| Current updates on EGFR and HER2 tyrosine kinase inhibitors for the breast cancer PS Dhiwar, GSP Matada, NM Raghavendra, A Ghara, E Singh, N Abbas, ... Medicinal Chemistry Research 31 (9), 1401-1413, 2022 | 4 | 2022 |
| Molecular recognition of some novel mTOR kinase inhibitors to develop anticancer leads by drug-likeness, molecular docking and molecular dynamics based virtual screening strategy A Das, GSP Matada, PS Dhiwar, NM Raghavendra, N Abbas, E Singh, ... Computational Toxicology 25, 100257, 2023 | 3 | 2023 |
| Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship PK Das, GSP Matada, R Pal, L Maji, PS Dhiwar, BV Manjushree, MP Viji European Journal of Medicinal Chemistry, 116535, 2024 | | 2024 |
| Nitrogen-Containing Heterocyclic Scaffolds as EGFR Inhibitors: Design Approaches, Molecular Docking, and Structure-Activity Relationships PSD Rohit Pal, Ghanshyam Teli, Prof. Dr. Gurubasavaraja Swamy Purawarga Matada Chemistry select, 2023 | | 2023 |
| Design and Synthesis of Tri-substituted Imidazole Derivatives as CD73 Inhibitors for Their Anticancer Activity A Ghara, GS Andhale, GSP Matada, PS Dhiwar Letters in Drug Design & Discovery 19 (3), 242-255, 2022 | | 2022 |
| Discovery of Novel Small-Molecule Tyrosine Kinase Inhibitors of Egfr and Her-2 by Ligand Based Virtual Screening. P Dhiwar, G Swamy PM Proceedings of International Conference on Drug Discovery (ICDD), 2020 | | 2020 |
Abhishek GharaAcharya & BM Reddy College of PharmacyVerified email at acharya.ac.in
